Type 1 diabetes mellitus in pediatrics

Pediatrics in Review

Volumn 29, Issue 11, 2008, Pages 374-385

  Cooke, David W ^a   Plotnick, Leslie ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; AUTOANTIBODY; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; KETONE; LONG ACTING INSULIN;

ABCC8 GENE; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLINDNESS; BLOOD GLUCOSE MONITORING; BOLUS INJECTION; BULIMIA; CALORIC INTAKE; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; DIABETIC KETOACIDOSIS; DIET; DOSE CALCULATION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RECEPTOR BINDING; EXERCISE; GENE; GENE MUTATION; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GROWTH DISORDER; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INCIDENCE; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN RELEASE; JUVENILE DIABETES MELLITUS; KCNJ11 GENE; KETONURIA; KIDNEY DISEASE; KIDNEY FAILURE; MATURITY ONSET DIABETES MELLITUS; MEDICAL INFORMATION; MORTALITY; NEUROPATHY; ONSET AGE; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PATHOGENESIS; PEDIATRICS; POLYDIPSIA; POLYURIA; RETINOPATHY; RISK FACTOR; RISK REDUCTION; SCREENING; SELF MONITORING; UNITED STATES; WEIGHT REDUCTION; ADOLESCENT; CHILD; EARLY DIAGNOSIS; FEMALE; HOSPITALIZATION; LIFESTYLE; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PRESCHOOL CHILD; PROGNOSIS; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

ADOLESCENT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 1; DIET; EARLY DIAGNOSIS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INCIDENCE; INSULIN; LIFE STYLE; MALE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 59849124635     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.29-11-374     Document Type: Article

References (9)

1. American Diabetes Association. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care. 2003;26: 2194-2197
2. Chase HP, Dixon B, Pearson J, et al. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and NPH. J Pediatr. 2003;143: 737-740
3. DCCT Research Group. The effect ofintensive diabetes treatment on long-term complications in adolescents with IDDM: the DCCT. J Pediatr. 1994;125:177-188
4. DCCT Research Group. The effect ofintensive diabetes treatment on the development and progression of long-term complications in IDDM: the DCCT. N Engl J Med. 1993;329:977-986
5. Expert Committee on the Diagnosis and Classification of Diabetes. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;S1:S42-S47
6. Jahromi MM, Eisenbarth GS. Cellular and molecular pathogenesis of type 1A diabetes. Cell Mol Lif Sci. 2007;64:865-872
7. Lueder GT, Silverstein J; American Academy of Pediatrics Section on Ophthalmology and Section on Endocrinology. Screening for retinopathy in the pediatric patient with type 1 diabetes. Pediatrics. 2005;116:270-273
8. Silverstein J, Klingensmith G, Copeland K, et al; American Diabetes Association. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28:186-212
9. White NH, Cleary PA, Dahma W, et al. Beneficial effects of intensive therapy ofdiabetes during adolescence: outcomes after the conclusion of the DCCT. J Pediatr. 2001;139:804-812